title: Key role for mast cells in nonatopic asthma.
abstract: The mechanisms involved in nonatopic asthma are poorly defined. In particular, the importance of mast cells in the development of nonatopic asthma is not clear. In the mouse, pulmonary hypersensitivity reactions induced by skin sensitization with the low-m.w. compound dinitrofluorobenzene (DNFB) followed by an intra-airway application of the hapten have been featured as a model for nonatopic asthma. In present study, we used this model to examine the role of mast cells in the pathogenesis of nonatopic asthma. First, the effect of DNFB sensitization and intra-airway challenge with dinitrobenzene sulfonic acid (DNS) on mast cell activation was monitored during the early phase of the response in BALB/c mice. Second, mast cell-deficient W/W(v) and Sl/Sl(d) mice and their respective normal (+/+) littermate mice and mast cell-reconstituted W/W(v) mice (bone marrow-derived mast cells-->W/W(v)) were used. Early phase mast cell activation was found, which was maximal 30 min after DNS challenge in DNFB-sensitized BALB/c, +/+ mice but not in mast cell-deficient mice. An acute bronchoconstriction and increase in vascular permeability accompanied the early phase mast cell activation. BALB/c, +/+ and bone marrow-derived mast cell-->W/W(v) mice sensitized with DNFB and DNS-challenged exhibited tracheal hyperreactivity 24 and 48 h after the challenge when compared with vehicle-treated mice. Mucosal exudation and infiltration of neutrophils in bronchoalveolar lavage fluid associated the late phase response. Both mast cell-deficient strains failed to show any features of this hypersensitivity response. Our findings show that mast cells play a key role in the regulation of pulmonary hypersensitivity responses in this murine model for nonatopic asthma.
authors.affiliation: Department of Pharmacology and Pathophysiology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. A.D.Kraneveld@pharm.uu.nl
authors.forename: Aletta D
authors.initials: AD
authors.lastname: Kraneveld
authors.forename: Hanneke P M
authors.initials: HP
authors.lastname: van der Kleij
authors.forename: Mirjam
authors.initials: M
authors.lastname: Kool
authors.forename: Anneke H
authors.initials: AH
authors.lastname: van Houwelingen
authors.forename: Andrys C D
authors.initials: AC
authors.lastname: Weitenberg
authors.forename: Frank A M
authors.initials: FA
authors.lastname: Redegeld
authors.forename: Frans P
authors.initials: FP
authors.lastname: Nijkamp
mesh_terms: D000818:Animals; D001249:Asthma / Q000209:etiology* / Q000276:immunology* / Q000473:pathology; D016084:Bronchoconstriction / Q000276:immunology; D002199:Capillary Permeability / Q000276:immunology; D004139:Dinitrofluorobenzene / Q000276:immunology; D004195:Disease Models, Animal; D007114:Immunization; D008297:Male; D008407:Mast Cells / Q000276:immunology* / Q000473:pathology / Q000637:transplantation; D051379:Mice; D008807:Mice, Inbred BALB C; D008817:Mice, Mutant Strains; D012130:Respiratory Hypersensitivity / Q000209:etiology / Q000276:immunology / Q000473:pathology; D013997:Time Factors
chemical_list: D004139:Dinitrofluorobenzene